甘酸通过调节Nrf2信号来减轻大鼠中5-甲诱导的卵性毒性:一种实验方法
Ahmet Mentese1, Selim Demir2, Esin Yulug3
1Department of Medical Services and Techniques, Vocational School of Health Services, Karadeniz Technical University, Trabzon 61080, Turkiye.
Reproductive toxicology (Elmsford, N.Y.)
|July 10, 2024
概括
甘酸 (GEA) 可能会防止5-Fluorouracil (5-FU) 化疗引起的卵巢损伤. 在老鼠中,GEA治疗激活了Nrf2通路,减少了氧化应激,改善了卵巢组织的健康.
科学领域:
- 生殖毒理学 生殖毒理学
- 化疗的副作用 化疗的副作用
- 抗氧化剂研究 抗氧化剂研究
背景情况:
- 5-Fluorouracil (5-FU) 是一种广泛使用的化疗剂,已知具有生殖毒性.
- 卵巢损伤是5-FU治疗的重要副作用.
- 甘酸 (GEA) 具有抗氧化特性,可在各种自然来源中发现.
研究的目的:
- 为了研究5-FU对大鼠卵巢组织的毒性作用.
- 评估GEA在缓解5-FU诱导的卵巢毒性的治疗潜力.
主要方法:
- 鼠被用5-FU治疗以诱导卵巢毒性.
- 为了评估其保护作用,在5FU治疗后给予GEA.
- 进行了组织病理学分析和途径评估 (Nrf2).
主要成果:
- 通过抑制Nrf2通路,5-FU诱导卵巢损伤,导致氧化应激增加,炎症,内质网膜应激和亡.
- GEA治疗剂量取决于改善了5-FU诱导的卵巢毒性.
- GEA激活了Nrf2通路,抵消了5-FU的有害影响.
结论:
- 在大鼠模型中,GEA证明了对5-FU诱导的卵巢损伤的治疗潜力.
- 保护机制涉及Nrf2通路的激活.
- 需要进一步的分子研究来探索GEA对接受5-FU化疗的妇女的益处.
更多相关视频
09:33Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
7.4K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
550
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K